Revelation Biosciences, Inc. (REVB) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 14.21M | 10.81M | 12.83M | 5.36M | 3.93M | 6.57M | 6.66M | 12.2M | 14.62M | 12.15M | 14.15M | 15.96M |
| Cash & Short-Term Investments | 14.11M | 10.7M | 12.71M | 5.17M | 3.7M | 6.5M | 6.54M | 12.07M | 14.55M | 11.99M | 13.99M | 15.71M |
| Cash Only | 14.11M | 10.7M | 12.71M | 5.17M | 3.7M | 6.5M | 6.54M | 12.07M | 14.55M | 11.99M | 13.99M | 15.71M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 92.62K | 33.95K | 123.93K | 186.05K | 223.27K | 49.5K | 74.85K | 56.95K | 67.98K | 100.61K | 81.39K | 107.51K |
| Total Non-Current Assets | 838.25K | 771.3K | 23.92K | 35.17K | 42.39K | 56.33K | 81.24K | 70.77K | 77.99K | 65.08K | 71.35K | 77.61K |
| Property, Plant & Equipment | 807.31K | 740.36K | 23.92K | 35.17K | 42.39K | 56.33K | 81.24K | 70.77K | 77.99K | 65.08K | 71.35K | 77.61K |
| Fixed Asset Turnover | - | - | - | - | - | 0.39x | - | - | - | 0.55x | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 30.94K | 30.94K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 15.04M | 11.58M | 12.86M | 5.4M | 3.97M | 6.62M | 6.74M | 12.27M | 14.7M | 12.21M | 14.22M | 16.04M |
| Asset Turnover | - | - | - | - | - | 0.00x | - | - | - | 0.00x | - | - |
| Asset Growth % | 278.92% | 74.91% | 90.74% | -56.03% | -72.99% | -45.78% | -52.6% | -23.5% | -18.86% | 121.91% | 115.38% | 286.11% |
| Total Current Liabilities | 1.42M | 2M | 1.85M | 1.57M | 1.09M | 1.91M | 4.07M | 11.13M | 5.23M | 5.56M | 5.4M | 4.62M |
| Accounts Payable | 828.2K | 577.5K | 1.03M | 828.89K | 625.06K | 783.62K | 3.13M | 1.28M | 1.68M | 1.36M | 1.26M | 913.87K |
| Days Payables Outstanding | 8.78K | - | - | - | - | 13.34K | 28.09K | 18.67K | 22.1K | 6.41K | 15.95K | 11.76K |
| Short-Term Debt | 120.86K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.91M | 0 |
| Other Current Liabilities | 468.08K | 0 | 819.56K | 336.32K | 464.46K | 2.25K | 4.8K | 9.39M | 3.3M | 3.44M | 723.93K | 3.38M |
| Current Ratio | 10.02x | 5.41x | 6.92x | 3.42x | 3.61x | 3.43x | 1.64x | 1.10x | 2.80x | 2.18x | 2.62x | 3.45x |
| Quick Ratio | 10.02x | 5.41x | 6.92x | 3.42x | 3.61x | 3.43x | 1.64x | 1.10x | 2.80x | 2.18x | 2.62x | 3.45x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 638.18K | 723.77K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Debt | 638.18K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 723.77K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 2.06M | 2.72M | 1.85M | 1.57M | 1.09M | 1.91M | 4.07M | 11.13M | 5.23M | 5.56M | 5.4M | 4.62M |
| Total Debt | 759.04K | 746.78K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Debt | -13.35M | -9.95M | -12.71M | -5.17M | -3.7M | -6.5M | -6.54M | -12.07M | -14.55M | -11.99M | -13.99M | -15.71M |
| Debt / Equity | 0.06x | 0.08x | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 12.99M | 8.86M | 11M | 3.83M | 2.88M | 4.71M | 2.67M | 1.14M | 9.47M | 6.65M | 8.82M | 11.41M |
| Equity Growth % | 350.89% | 88.2% | 311.5% | 235.47% | -69.59% | -29.17% | -69.68% | -90.01% | -5.44% | 531.64% | 295.86% | 719.36% |
| Book Value per Share | 4.05 | 14.27 | 4.16 | 4.77 | 2.97 | 13.59 | 15.96 | 11.16 | 139.08 | 402.09 | 672.19 | 942.75 |
| Total Shareholders' Equity | 12.99M | 8.86M | 11M | 3.83M | 2.88M | 4.71M | 2.67M | 1.14M | 9.47M | 6.65M | 8.82M | 11.41M |
| Common Stock | 3.91K | 1.58K | 3.59K | 1.53K | 964 | 522 | 4.29K | 1.64K | 1.63K | 265 | 6.3K | 6.3K |
| Retained Earnings | -52.43M | -49.42M | -46.91M | -45M | -42.56M | -40.51M | -38.78M | -36.54M | -28.15M | -25.47M | -23.26M | -20.64M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |